These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31048034)

  • 1. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ
    Maurice T; Volle JN; Strehaiano M; Crouzier L; Pereira C; Kaloyanov N; Virieux D; Pirat JL
    Pharmacol Res; 2019 Jun; 144():315-330. PubMed ID: 31048034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease.
    Carles A; Hoffmann M; Scheiner M; Crouzier L; Bertrand-Gaday C; Chatonnet A; Decker M; Maurice T
    CNS Neurosci Ther; 2024 Jun; 30(6):e14814. PubMed ID: 38887858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of σ
    Maurice T; Goguadze N
    Adv Exp Med Biol; 2017; 964():213-233. PubMed ID: 28315274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma 1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative.
    Villard V; Espallergues J; Keller E; Vamvakides A; Maurice T
    J Psychopharmacol; 2011 Aug; 25(8):1101-17. PubMed ID: 20829307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
    Fisher A; Bezprozvanny I; Wu L; Ryskamp DA; Bar-Ner N; Natan N; Brandeis R; Elkon H; Nahum V; Gershonov E; LaFerla FM; Medeiros R
    Neurodegener Dis; 2016; 16(1-2):95-110. PubMed ID: 26606130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.
    Yang R; Chen L; Wang H; Xu B; Tomimoto H; Chen L
    Neuropharmacology; 2012 Nov; 63(6):1042-50. PubMed ID: 22884465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
    Meunier J; Ieni J; Maurice T
    Br J Pharmacol; 2006 Dec; 149(8):998-1012. PubMed ID: 17057756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease.
    Freyssin A; Carles A; Guehairia S; Rubinstenn G; Maurice T
    Neuropharmacology; 2024 Jan; 242():109733. PubMed ID: 37844867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.
    Yi B; Sahn JJ; Ardestani PM; Evans AK; Scott LL; Chan JZ; Iyer S; Crisp A; Zuniga G; Pierce JT; Martin SF; Shamloo M
    J Neurochem; 2017 Feb; 140(4):561-575. PubMed ID: 27926996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine acts as a positive modulator of sigma-1 receptors.
    Martin P; de Witte PAM; Maurice T; Gammaitoni A; Farfel G; Galer B
    Epilepsy Behav; 2020 Apr; 105():106989. PubMed ID: 32169824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model.
    Lahmy V; Long R; Morin D; Villard V; Maurice T
    Front Cell Neurosci; 2014; 8():463. PubMed ID: 25653589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease.
    Lee YW; Kim DH; Jeon SJ; Park SJ; Kim JM; Jung JM; Lee HE; Bae SG; Oh HK; Son KH; Ryu JH
    Eur J Pharmacol; 2013 Mar; 704(1-3):70-7. PubMed ID: 23461850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress.
    Goguadze N; Zhuravliova E; Morin D; Mikeladze D; Maurice T
    Neurotox Res; 2019 Jan; 35(1):1-18. PubMed ID: 29127580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats".
    Badawi GA; Shokr MM; Elshazly SM; Zaki HF; Mohamed AF
    Eur J Pharmacol; 2024 Oct; 980():176851. PubMed ID: 39084454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
    Maurice T; Su TP; Privat A
    Neuroscience; 1998 Mar; 83(2):413-28. PubMed ID: 9460750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.